Late Breaking Oral Abstract Session
Thursday, May 30, 2024 05:00 PM - 06:00 PM
Room 202-204
Abstract Presentations
- A pilot, first in human study of autologous IFN-gamma stimulated, refreshed autologous bone marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia – 1 year results, Randall J Kimple, United States
- Tuning Car-T Cell Phenotype Through Enhanced Bioprocess Control In An Automated Stirred-Tank Bioreactor, Marta Costa, Portugal
- TGFBR2 Knockout CAR NK-92MI Cells Targeting Mesothelin Show Promise in Overcoming Pancreatic Tumor Microenvironment, Oksana V Gruzdyn, United States
- Single-Dose GLP-1-Based Pancreatic Gene Therapy Produces Sustained Lowering Of Blood Glucose And Body Weight In Murine Models Of Diabetes And Obesity, Timothy J. Kieffer, United States
- Evaluation of a high-expression FVIII transgene and lentiviral vector-transduced autologous CD34+ hematopoietic stem cells in a phase 1 clinical trial of gene therapy for hemophilia A, H. Trent Spencer, United States
- Safety and Efficacy results from a Phase 1/2 Clinical trial of OCU400 modifier gene therapy for treatment of retinitis pigmentosa, Arun Kumar Upadhyay, United States
